March 6, 2018 / 12:41 PM / 2 months ago

BRIEF-ProMIS Neurosciences Lead Product Candidate For Alzheimer's Disease Shows Potential For Improved Therapeutic Potency

March 6 (Reuters) - ProMIS Neurosciences Inc:

* PROMIS NEUROSCIENCES LEAD PRODUCT CANDIDATE FOR ALZHEIMER’S DISEASE SHOWS POTENTIAL FOR IMPROVED THERAPEUTIC POTENCY VERSUS OTHER AMYLOID BETA-DIRECTED ANTIBODIES

* PROMIS NEUROSCIENCES INC - PMN310 SHOWED SIMILAR ABILITY TO CROSS BLOOD BRAIN BARRIER AND PENETRATE CENTRAL NERVOUS SYSTEM COMPARED TO ADUCANUMAB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below